Back to Search
Start Over
Albireo Recognizes Rare Disease Day and Supports Global Effort to 'Reframe Rare' By Highlighting the Challenges of Cholestatic Liver Disorders
- Source :
- GlobeNewswire. February 27, 2020
- Publication Year :
- 2020
-
Abstract
- BOSTON, Feb 27, 2020 (GLOBE NEWSWIRE via COMTEX) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced its support for [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.615355812